⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL490333 | 0.69 | — | — | |
| SCHEMBL3073245 | 0.67 | — | — | |
| SCHEMBL9569884 | 0.62 | — | — | |
| SCHEMBL4026431 | 0.57 | — | — | |
| SCHEMBL6873550 | 0.57 | — | — | |
| SCHEMBL16114785 | 0.53 | — | — | |
| SCHEMBL11954073 | 0.50 | — | — | |
| SCHEMBL3117258 | 0.50 | — | — | |
| SCHEMBL546296 | 0.50 | MAPT (0.56) | — | |
| SCHEMBL9086142 | 0.50 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 333 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3368089-A1 | NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACID COMPLEXES | TRANSLATE BIO MA, INC. (US) | 2018-09-05 | — | — | EP | claimed |
| EP-2678079-B1 | OXIDATIVE DYEING COMPOSITIONS COMPRISING AN 1-HEXYL/HEPTYL-4,5-DIAMINOPYRAZOLE AND A BENZO[1,3]DIOXOL-5-YLAMINE AND DERIVATIVES THEREOF | NOXELL CORP (US) | 2017-08-02 | — | — | EP | claimed |
| WO-2017075038-A1 | NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACID COMPLEXES | RANA THERAPEUTICS, INC. (US) | 2017-05-04 | — | — | WO | claimed |
| CN-103458863-B | Comprise 1-hexyl/heptyl-4, the oxidative coloration composition of 5-diamino-pyrazole and benzo [1,3] dioxole-5-base amine and derivative thereof | THE PROCTER & GAMBLE CO. (US) | 2016-05-04 | — | — | CN | claimed |
| CN-103443074-B | Heterocyclic amine derivative | HOFFMAN-LA ROCHE LTD. (CH) | 2016-04-13 | — | — | CN | claimed |
| CN-103237801-B | Quinoline or quinazoline derivatives having apoptosis-inducing activity on cells | HANMI HOLDINGS Co.,Ltd. (KR) | 2015-11-25 | — | — | CN | claimed |
| CN-105026411-A | Ribonucleic acids with 4'-thio-modified nucleotides and related methods | SHIRE HUMAN GENETIC THERAPIES | 2015-11-04 | — | — | CN | claimed |
| CN-104922699-A | LIPID FORMULATED COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Eg5 AND VEGF GENES | ALNYLAM PHARMACEUTICALS INC | 2015-09-23 | — | — | CN | claimed |
| CN-104651408-A | Lipid formulated siRNA targeted to PCSK9 gene | ALNYLAM PHARMACEUTICALS INC | 2015-05-27 | — | — | CN | claimed |
| CN-103458863-A | Oxidative dyeing composition comprising 1-hexyl/heptyl-4,5-diaminopyrazole and benzo[1,3]dioxol-5-ylamine and derivatives thereof | PROCTER & GAMBLE | 2013-12-18 | — | — | CN | claimed |
| CN-103443074-A | Heterocyclic amine derivatives | HOFFMANN LA ROCHE | 2013-12-11 | — | — | CN | claimed |
| CN-103237801-A | Quinoline or quinazoline derivatives having apoptosis-inducing activity on cells | HANMI HOLDINGS CO LTD | 2013-08-07 | — | — | CN | claimed |
| CN-102458366-A | Lipid formulated DSRNA targeting PCSK9 gene | ALNYLAM PHARMACEUTICALS INC | 2012-05-16 | — | — | CN | claimed |
| CN-102421900-A | Lipid formulated compositions and methods for inhibiting expression of eg5 and vegf genes | ALNYLAM PHARMACEUTICALS INC | 2012-04-18 | — | — | CN | claimed |
| WO-2026102082-A1 | ALKYLPHENYL SUBSTITUTED COMPOUNDS, COMPOSITIONS AND METHODS OF USE | DEEP APPLE THERAPEUTICS, INC. (US) | 2026-05-15 | — | — | WO | disclosed |
| EP-4727943-A1 | INHIBITORS OF MET KINASE | Celyn Therapeutics, Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| US-12545636-B2 | Acyclic lipids and methods of use thereof | RENAGADE THERAPEUTICS MANAGEMENT INC. (US) | 2026-02-10 | — | — | US | disclosed |
| CN-1478088-A | Benzothiophene derivatives, process for their preparation and their use | ά��ʵ��������˾ | 2004-02-25 | — | — | CN | disclosed |
| EP-1337528-A2 | BENZOTHIOPHENE DERIVATIVE COMPOUNDS, PROCESS OF PREPARATION AND USE THEREOF | LABORATORIOS VITA, S.A. (ES) | 2003-08-27 | — | — | EP | disclosed |
| WO-2002044170-A2 | BENZOTHIOPHENE DERIVATIVE COMPOUNDS, PROCESS OF PREPARATION AND USE THEREOF | LABORATORIOS VITA, S.A. (ES) | 2002-06-06 | — | — | WO | disclosed |